IP Library Granted Patent US 10,772,681
Granted Patent B2
US 10,772,681 · App. 15/662,179 · Granted Sep 15, 2020

Energy delivery to intraparenchymal regions of the kidney

Inventor: Michael Gertner (Menlo Park, CA)
Assignee: Utsuka Medical Devices Co., Ltd.
A61B18/1492A61B5/01A61B5/055A61B90/50A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/048A61N7/02A61N7/022A61N2007/0021A61N2007/0078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,772,681
App. No.
15/662,179
Granted
Sep 15, 2020
Kind
B2
Abstract

A method to apply a nerve inhibiting cloud surrounding a blood vessel includes creating a treatment plan, wherein the treatment plan prescribes application of the nerve inhibiting cloud towards at least a majority portion of a circumference of a blood vessel wall, and applying the nerve inhibiting cloud towards the majority portion of the circumference of the blood vessel wall for a time sufficient to inhibit a function of a nerve that surrounds the blood vessel wall.

Claims (25)

1. A method to treat hypertension comprising:

advancing a catheter into a kidney of a patient; and

delivering energy from the catheter to target intra-parenchymal tissue inside the kidney;

wherein the energy is delivered to create a flow-restricting lesion inside the kidney.

2. The method of claim 1 , wherein the energy is radiofrequency energy.

3. The method of claim 1 , wherein the energy is x-ray.

4. The method of claim 1 , wherein the energy is microwave energy.

5. The method of claim 1 , wherein the energy is ultrasound energy.

6. The method of claim 1 , wherein the catheter is placed in a hilum of the kidney.

7. The method of claim 1 , wherein the catheter is configured to generate vibratory energy.

8. The method of claim 1 , wherein the flow-restricting lesion is created at a hilum of the kidney to activate mechanoreceptors inside the kidney to send signals to a brain of the patient.

9. The method of claim 1 , wherein the flow-restricting lesion is created inside the kidney to affect a hormone generating region inside the kidney.

10. The method of claim 1 , wherein the flow-restricting lesion is created inside or on a vein inside the kidney to create a high intra-parenchymal pressure.

11. The method of claim 1 , wherein the act of advancing the catheter into the kidney of the patient comprises advancing the catheter into an intra-parenchymal region of the kidney.

12. A method to treat hypertension comprising:

advancing a catheter into a kidney of a patient; and

delivering energy from the catheter to target intra-parenchymal tissue of the kidney until a flow-restricting lesion is created;

wherein the flow-restricting lesion causes a rise in an intra-parenchymal pressure of the kidney.

13. The method of claim 12 , wherein the energy is radiofrequency energy.

14. The method of claim 12 , wherein the energy is ultrasound energy.

15. The method of claim 12 , wherein the catheter is coupled to an energy source outside the patient.

16. The method of claim 12 , wherein the intra-parenchymal tissue comprises a hormone producing region of the kidney.

17. The method of claim 12 , wherein the act of advancing the catheter into the kidney of the patient comprises advancing the catheter into an intra-parenchymal vasculature of the kidney.

18. The method of claim 17 , wherein the intra-parenchymal vasculature is an arterial vasculature.

19. The method of claim 17 , wherein the intra-parenchymal vasculature is a venous vasculature.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: KONA MEDICAL, INC.
To: OTSUKA MEDICAL DEVICES CO., LTD.
Reel/Frame 052309/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2020
From: GERTNER, MICHAEL
To: KONA MEDICAL, INC.
Reel/Frame 052018/0223 →
Continuity (14)
Continuation 14939670 · Nov 12, 2015
Continuation 13896247 · May 16, 2013
Continuation 13048842 · Mar 15, 2011
Continuation In Part 12902133 · Oct 11, 2010
Continuation In Part 12725450 · Mar 16, 2010
Continuation In Part 12685655 · Jan 11, 2010
Provisional Application 61377908 · Aug 27, 2010
Provisional Application 61347375 · May 21, 2010
Provisional Application 61256983 · Oct 31, 2009
Provisional Application 61250857 · Oct 12, 2009
Provisional Application 61261741 · Nov 16, 2009
Provisional Application 61291359 · Dec 30, 2009
Provisional Application 61303307 · Feb 10, 2010
Related Publication 20170325880A1 · Nov 16, 2017
Cited By (1)
US 12,478,806